Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias
Researchers from The University of Texas MD Anderson Cancer Center are presenting compelling findings from three clinical trials at the 2022 American Society of Hematology Annual Meeting.
Source: news-medical.net